Gene Re-expression in Calu6 Tumors Following Epigenetic Therapy
Ontology highlight
ABSTRACT: Transciptional profiling of Calu6 tumors comparing 4 pooled untreated tumors to 5-azacytodine or 5-azacytodine + MS-275 (combined therapy) treated tumors Three-condition experiment, untreated vs. 5-Azacytodine tumors, and untreated vs. 5-azacytodine + MS-275 tumors: 4 pooled untreated tumors; 4 5-Azacytodine treated, 4 5-Azacytodine + MS-275 treated. Study used a loop design with dye-swap.
ORGANISM(S): Homo sapiens
SUBMITTER: Steven Belinsky
PROVIDER: E-GEOD-24732 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA